An AI-based platform, VIPER, triaged study participants across 20 different cancer studies simultaneously, allowing identification of patients for interventional studies (previously not attempted at the hospital due to resource constraints).

What you will learn in this Abstract:

  • Why AI is more efficient than the current system for identifying candidates for clinical trials
  • How new technology can identify potential patients for clinical trials previously not identified due to resource constraints
  • Learn about the future directions for research

Download this Abstract to learn more about the VIPER technology by Deep Lens.